Companies That Give Back
Channel your investments toward companies that make philanthropy a priority. These stocks have been carefully selected by our analysts for their commitment to giving back while building sustainable businesses that could deliver long-term value to investors.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Alphabet Inc (Google)
GOOGL
Current price
$201.57
Through Google.org, the company directs substantial funding and technological resources to address global challenges like climate change and public he...
Through Google.org, the company directs substantial funding and technological resources to address global challenges like climate change and public health.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
Companies that prioritize giving back often build stronger brands and more sustainable business models. These firms demonstrate their values through significant charitable giving and community programs, potentially positioning them for loyal customers and long-term stability.
What You Need to Know
This collection spans diverse sectors including technology, healthcare, retail, and consumer goods. Each company has earned recognition for their philanthropic initiatives, from product donations to community development. Their social responsibility may signal good governance and sustainable business practices.
Why These Stocks
These companies weren't selected randomly—they've demonstrated consistent commitment to philanthropy through foundations, financial contributions, and volunteering programs. With growing investor interest in ESG factors, these firms may be well-positioned as values-based investing continues to gain momentum.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+13.87%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 13.87% over the next year.
Stocks Rated Buy by Analysts
14 of 17 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 2% return last month.
Why You'll Want to Watch These Stocks
Do Well While Doing Good
These companies aren't just writing checks—they've built giving into their business models. As consumers increasingly support brands that share their values, these firms may have an edge in building customer loyalty.
The ESG Momentum
ESG investing is gaining serious traction. With more investors looking for socially responsible companies, these philanthropic leaders could experience increased demand and potentially attractive valuations.
Tomorrow's Business Leaders
Companies that focus on community impact often attract and retain top talent while building more resilient business models. Their long-term perspective might translate to sustainable growth that outlasts market cycles.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.